PQA || Research Coordinating Council

Phase II Demonstration Projects Executive Summaries: Jan. 2010 Highlights/Updates from Phase I Demo Projects: 2009

PQA Quality Connection

Information and application form PQA Members

Annual Meeting Materials

2010 Quality Metrics Workgroups PQA-Endorsed Starter Set of Measures Environmental Scan of Measures Resources

Measure Uptake & Implementation

Information about the Communications & Education Workgroup

Information about the Research Coordinating Council Phase II Demonstration Projects Executive Summaries: Jan. 2010

PQA News and Press Releases

Questions or Comments? Please Contact Us.

RESEARCH COORDINATING COUNCIL

This workgroup will be comprised of 12-15 members and will include researchers, community pharmacists, and personnel from drug plans and potential data aggregators. The group will provide ongoing input to research initiatives being undertaken by PQA, including the 2010 Phase II Demonstration Projects.

Co-Chairs:

Eleanor M. Perfetto, PhD, MS, Senior Director, Reimbursement & Regulatory Affairs
Federal Government Relations
Pfizer Inc

Kristina Yu-Isenberg, PhD, MPH, RPh, Director, Regional Outcomes Research
US Medical Affairs - Southeast Operating Unit

Novartis Pharmaceuticals Corporation